TSU will train chemists for biomedicine

The Tomsk State University has begun admission to the new cross-disciplinary Master's programme Translational Chemical and Biomedical Technologies, which has no direct analogs in Russia.

The new programme will prepare professionals in the development of new chemicals and materials for biomedical applications and modern diagnostic and therapeutic methods and means. It is implemented from the Laboratory for Translational Cell and Molecular Biomedicine, which was established at TSU two years ago.

- This expert knows not only how to get the new material, but also has an idea of what is happening with this material in the body and which processes can be run at the level of the immune system. Such a specialist knows which substances can be used as components for new materials, and which absolutely cannot be used because they are dangerous to humans, - says Irina Kurzina, head of the Laboratory for Translational Cell and Molecular Biomedicine.

Similar graduate programmes exist abroad and are very popular, despite their high tuition fees, because people understand that the future belongs to interdisciplinary specialties, and are ready to invest money.

The programme of Heidelberg University (Germany), a longstanding partner of TSU, was taken as an example. But TSU filled it with courses on the preparation of biologically active compounds, the chemical basics of molecular biology and genetic engineering, and chemical engineering in medicine, as well as the basics of marketing in the chemical and pharmaceutical industries. More than half of the courses are planned to be taken by choice, which means that each graduate student will be able to choose an individual educational trajectory. Among the teachers are doctors of chemical, biological and medical sciences, medical practitioners, and Russian and international experts.

Not only laboratories of the Faculty of Chemistry with their fundamental research in synthesis of new materials, including biocompatibles, will be a platform for specialist training, but also the Cancer Research Institute of Russian Academy of Medical Science and Research Institute of Cardiology of RAMS, where Master’s students will take practicums to prepare their Master's theses. In addition, the partners of the programme are Heidelberg University (Germany); University of Münster (Germany); MakroTehoHG (Münster, Germany); and Leiden University (Netherlands), which will allow students to take internships in international universities and research centres.

Budgeted admission is planned for 10 people; admission on a commercial basis is also scheduled. Detailed information on the conditions of admissions and contact details are available on the website.